| Cash and cash equivalents |
8.39M |
| Marketable securities |
31.16M |
| Collaboration receivable |
| Prepaid expenses and other current assets |
1.63M |
| Total current assets |
41.19M |
| Property and equipment, net |
1.48K |
| Other assets |
| Total assets |
41.51M |
| Accounts payable |
1.16M |
| Accrued contract research costs |
| Other accrued liabilities |
| Capital lease obligations |
| Deferred collaboration revenue |
| Current portion of term loans |
| Total current liabilities |
3.92M |
| Capital lease obligations |
| Deferred collaboration revenue |
| Term loans, net of current portion |
| Total long-term liabilities |
| Total liabilities |
3.92M |
| Preferred stock, par value $0.0001 per share Authorized: 5,000,000 shares at June 30, 2011 and December 31, 2010; no shares issued and outstanding at June 30, 2011 and December 31, 2010 |
0 |
| Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at June 30, 2011 and December 31, 2010; 49,473,070 and 42,090,205 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
1.16K |
| Additional paid-in-capital |
105.16M |
| Accumulated other comprehensive income (loss) |
-12.49K |
| Accumulated deficit |
-67.56M |
| Total stockholders' equity |
| Total liabilities and stockholders' equity |
41.51M |
